Mark F. Bird

Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)

Mark F. Bird, Maria Camilla Cerlesi, Mark J. Brown et al. · PLoS ONE · 2016 · 55 citations · Full text

<i>In vitro</i> and <i>in vivo</i> pharmacological characterization of nociceptin/orphanin <scp>FQ</scp> tetrabranched derivatives

A. Rizzi, Davide Malfacini, Maria Camilla Cerlesi et al. · British Journal of Pharmacology · 2014 · 32 citations · Full text

In vitro pharmacological characterization of a novel unbiased <scp>NOP</scp> receptor‐selective nonpeptide agonist <scp>AT</scp>‐403

Federica Ferrari, Davide Malfacini, V. Blair Journigan et al. · Pharmacology Research & Perspectives · 2017 · 29 citations · Full text

Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)

Maria Camilla Cerlesi, Huiping Ding, Mark F. Bird et al. · European Journal of Pharmacology · 2016 · 27 citations · Full text

Molecular Pharmacology, Pharmacological Studies, Functional Selectivity +9

Nociceptin/Orphanin <scp>FQ</scp> (N/OFQ) conjugated to <scp>ATTO</scp>594: a novel fluorescent probe for the N/OFQ (NOP) receptor

Mark F. Bird, Renzo Guerrini, Jonathon M. Willets et al. · British Journal of Pharmacology · 2018 · 22 citations · Full text